AXM Pharma, Inc. engages in the production, marketing, and distribution of pharmaceutical products. The company is headquartered in New York City, New York and currently employs 150 full-time employees. The company went IPO on 2001-02-02. The firm provides pharmaceutical products. The firm's pharmaceutical products include Complete Lice Treatment Kit, Cranberry Tablets, Chest Congestion relief, Lice Killing Shampoo and Ear Wax Removal Aid. The firm delivers its medicines to customers through the United States Postal Service (U.S.P.S.) or the United Parcel Service (U.P.S. ).
根據最新的財務報表(Form-10K),Oaktree Acquisition III Life Sciences Corp 的總資產為 $0,淨isProfitable}為 $0
AXMP 的關鍵財務比率是什麼?
Oaktree Acquisition III Life Sciences Corp 的流動比率為 0,淨利潤率為 0,每股銷售為 $0。
Aaron Sparks Industries Inc 的收入按細分市場或地理位置如何劃分?
Oaktree Acquisition III Life Sciences Corp 最大收入來源為 Print,在最近的收益報告中收入為 715,000,000。就地區而言,United States 是 Oaktree Acquisition III Life Sciences Corp 的主要市場,收入為 511,000,000。
Aaron Sparks Industries Inc 是否盈利?
無,根據最新的財務報表,Oaktree Acquisition III Life Sciences Corp 的淨損失為 $0
Aaron Sparks Industries Inc 有負債嗎?
無,Oaktree Acquisition III Life Sciences Corp 的負債為 0
Aaron Sparks Industries Inc 的流通股有多少?
Oaktree Acquisition III Life Sciences Corp 的總流通股為 0